246 related articles for article (PubMed ID: 26864319)
21. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Januzzi JL; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Cohen-Solal A; Richards AM; Launay JM; Mebazaa A;
JACC Heart Fail; 2015 Aug; 3(8):629-36. PubMed ID: 26251090
[TBL] [Abstract][Full Text] [Related]
22. Exposing the High Heterogeneity of Circulating Pro B-Type Natriuretic Peptide Fragments in Healthy Individuals and Heart Failure Patients.
Amplatz B; Sarg B; Faserl K; Hammerer-Lercher A; Mair J; Lindner HH
Clin Chem; 2020 Sep; 66(9):1200-1209. PubMed ID: 32797158
[TBL] [Abstract][Full Text] [Related]
23. A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein.
Crimmins DL; Kao JL
Arch Biochem Biophys; 2008 Jul; 475(1):36-41. PubMed ID: 18440296
[TBL] [Abstract][Full Text] [Related]
24. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Solomon SD; Zile M; Pieske B; Voors A; Shah A; Kraigher-Krainer E; Shi V; Bransford T; Takeuchi M; Gong J; Lefkowitz M; Packer M; McMurray JJ;
Lancet; 2012 Oct; 380(9851):1387-95. PubMed ID: 22932717
[TBL] [Abstract][Full Text] [Related]
25. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
26. Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.
Semenov AG; Tamm NN; Apple FS; Schulz KM; Love SA; Ler R; Feygina EE; Katrukha AG
Clin Biochem; 2017 Mar; 50(4-5):181-185. PubMed ID: 27823960
[TBL] [Abstract][Full Text] [Related]
27. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
28. ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.
Lewis LK; Raudsepp SD; Prickett TCR; Yandle TG; Doughty RN; Frampton CM; Pemberton CJ; Richards AM
Clin Chem; 2019 Sep; 65(9):1115-1124. PubMed ID: 31092393
[TBL] [Abstract][Full Text] [Related]
29. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.
Semenov AG; Postnikov AB; Tamm NN; Seferian KR; Karpova NS; Bloshchitsyna MN; Koshkina EV; Krasnoselsky MI; Serebryanaya DV; Katrukha AG
Clin Chem; 2009 Mar; 55(3):489-98. PubMed ID: 19168558
[TBL] [Abstract][Full Text] [Related]
30. New issues on measurement of B-type natriuretic peptides.
Clerico A; Zaninotto M; Passino C; Plebani M
Clin Chem Lab Med; 2017 Nov; 56(1):32-39. PubMed ID: 28809748
[TBL] [Abstract][Full Text] [Related]
31. B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
Nishikimi T; Nakagawa Y
Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101415
[TBL] [Abstract][Full Text] [Related]
32. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
[TBL] [Abstract][Full Text] [Related]
33. Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
DeVore AD; Braunwald E; Morrow DA; Duffy CI; Ambrosy AP; Chakraborty H; McCague K; Rocha R; Velazquez EJ;
JAMA Cardiol; 2020 Feb; 5(2):202-207. PubMed ID: 31825471
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction.
Kobalava Z; Kotovskaya Y; Averkov O; Pavlikova E; Moiseev V; Albrecht D; Chandra P; Ayalasomayajula S; Prescott MF; Pal P; Langenickel TH; Jordaan P; Rajman I
Cardiovasc Ther; 2016 Aug; 34(4):191-8. PubMed ID: 26990595
[TBL] [Abstract][Full Text] [Related]
35. Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure.
Nishikimi T; Okamoto H; Nakamura M; Ogawa N; Horii K; Nagata K; Nakagawa Y; Kinoshita H; Yamada C; Nakao K; Minami T; Kuwabara Y; Kuwahara K; Masuda I; Kangawa K; Minamino N; Nakao K
PLoS One; 2013; 8(1):e53233. PubMed ID: 23365636
[TBL] [Abstract][Full Text] [Related]
36. Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA; Brown NJ
Circulation; 2016 Mar; 133(11):1115-24. PubMed ID: 26976916
[TBL] [Abstract][Full Text] [Related]
37. Characterization of molecular forms of probrain natriuretic peptide in human plasma.
Shimizu H; Masuta K; Asada H; Sugita K; Sairenji T
Clin Chim Acta; 2003 Aug; 334(1-2):233-9. PubMed ID: 12867297
[TBL] [Abstract][Full Text] [Related]
38. Immunodetection of glycosylated NT-proBNP circulating in human blood.
Seferian KR; Tamm NN; Semenov AG; Tolstaya AA; Koshkina EV; Krasnoselsky MI; Postnikov AB; Serebryanaya DV; Apple FS; Murakami MM; Katrukha AG
Clin Chem; 2008 May; 54(5):866-73. PubMed ID: 18339697
[TBL] [Abstract][Full Text] [Related]
39. The precursor to B-type natriuretic peptide is an O-linked glycoprotein.
Schellenberger U; O'Rear J; Guzzetta A; Jue RA; Protter AA; Pollitt NS
Arch Biochem Biophys; 2006 Jul; 451(2):160-6. PubMed ID: 16750161
[TBL] [Abstract][Full Text] [Related]
40. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus.
Walther T; Stepan H; Pankow K; Gembardt F; Faber R; Schultheiss HP; Siems WE
BJOG; 2004 May; 111(5):452-5. PubMed ID: 15104609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
